Vermont Business Magazine Vermont Attorney General Bill Sorrell has reached anagreementwith Amphastar Pharmaceuticals, Incthat addresses concerns with the 2014 price increase of the opioid antidote drug Naloxone. Amphastar, the manufacturer of Naloxone, has agreed to provide the drug to Vermont state and local governments and associated agencies at 20 percent less than the wholesale price. Under the agreement, Amphastar will provide a $6 per dose rebate for each syringe purchased over the next year, and increase the rebate to match any increase in Naloxone’s wholesale price.
“Opioid addiction is a battle we are fighting hard in Vermont on several fronts,” said Attorney General Sorrell. “Naloxone has already saved the lives of Vermonters. Affordable access to this drug is a critical component of addressing the opioid crisis.”
Vermont AG: Dec 18, 2015